"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 4 | 3 | 7 |
| 1998 | 4 | 1 | 5 |
| 1999 | 5 | 3 | 8 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 4 | 6 |
| 2002 | 9 | 7 | 16 |
| 2003 | 6 | 4 | 10 |
| 2004 | 1 | 2 | 3 |
| 2005 | 3 | 1 | 4 |
| 2006 | 7 | 6 | 13 |
| 2007 | 6 | 2 | 8 |
| 2008 | 7 | 9 | 16 |
| 2009 | 9 | 8 | 17 |
| 2010 | 3 | 2 | 5 |
| 2011 | 10 | 2 | 12 |
| 2012 | 7 | 6 | 13 |
| 2013 | 9 | 9 | 18 |
| 2014 | 7 | 3 | 10 |
| 2015 | 8 | 8 | 16 |
| 2016 | 8 | 4 | 12 |
| 2017 | 4 | 7 | 11 |
| 2018 | 7 | 4 | 11 |
| 2019 | 6 | 9 | 15 |
| 2020 | 3 | 6 | 9 |
| 2021 | 4 | 11 | 15 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 3 | 4 |
| 2025 | 2 | 1 | 3 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Muscarinic 3 receptor antibodies in Sj?gren's disease: Evaluating assay variability and detection methods. J Immunol Methods. 2026 Mar; 547:114038.
-
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management. Int Ophthalmol Clin. 2026 Jan 01; 66(1):12-24.
-
Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sj?gren's Disease. Int J Mol Sci. 2025 Sep 10; 26(18).
-
Cardiac autoantibodies promote a fibrotic transcriptome and reduced ventricular recovery in human myocarditis. Front Immunol. 2025; 16:1500909.
-
A relook at the relevance of thyroid stimulating hormone and thyroid autoimmunity for pregnancy outcomes: Analyses of randomized control trials data from Pregnancy in Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation. Fertil Steril. 2025 May; 123(5):873-882.
-
Engineered human heart tissue reveals pathogenicity of autoantibodies in systemic lupus erythematosus. Nat Cardiovasc Res. 2024 Sep; 3(9):1028-1030.
-
Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion. Neurol Neuroimmunol Neuroinflamm. 2024 Jul; 11(4):e200268.
-
Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report. BMC Ophthalmol. 2024 Feb 13; 24(1):61.
-
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 02 23; 62(SI2):SI226-SI234.
-
Anti-vimentin antibodies are associated with higher severity of Sj?gren's disease. Clin Immunol. 2023 02; 247:109243.